Login / Signup
Comparative predictive efficacy of atherogenic indices on metabolic syndrome in patients with schizophrenia.
Yu-Tung Tien
Liang-Jen Wang
Yu Lee
Pao-Yen Lin
Chi-Fa Hung
Mian-Yoon Chong
Yu-Chi Huang
Published in:
Schizophrenia research (2023)
Among atherogenic indices, only AIP has superior discrimination for detecting metabolic syndrome in schizophrenia with antipsychotics treatment.
Keyphrases
</>
metabolic syndrome
insulin resistance
uric acid
bipolar disorder
cardiovascular risk factors
low density lipoprotein
cardiovascular disease
type diabetes